Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer

QTNM: a simplified TNM or just another staging system?

Numerous risk-group stratification, staging and scoring systems exist to stratify patients with differentiated thyroid cancer into prognostic risk groups that guide patient management decisions. The tumor–node–metastasis staging system is the most widely adopted despite its relative complexity, but could a simplified, quantitative alternative to the system provide superior prognostic value?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Onitilo, A. A. et al. Simplifying TNM system for clinical use in differentiated thyroid cancer. J. Clin. Oncol. 27, 1872–1878 (2009).

    Article  Google Scholar 

  2. Greene, F. L. et al. (Eds) AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumours, 6th edn (Springer-Verlag, New York, 2002).

    Book  Google Scholar 

  3. Burke, H. B. Outcome prediction and the future of the TNM staging system. J. Natl Cancer Inst. 96, 1408–1409 (2004).

    Article  Google Scholar 

  4. Hay, I. D., Bergstralh, E. J., Goellner, J. R., Ebersold, J. R. & Grant, C. S. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated in one institution during 1940 through 1989. Surgery 114, 1050–1057 (1993).

    CAS  PubMed  Google Scholar 

  5. Beenken, S. et al. Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am. J. Surg. 179, 51–56 (2000).

    Article  CAS  Google Scholar 

  6. Cady, B. & Rossi, R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104, 947–953 (1988).

    CAS  PubMed  Google Scholar 

  7. Lang, B. H., Lo, C. Y., Chan, W. F., Lam, K. Y. & Wan, K. Y. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann. Surg. 245, 366–378 (2007).

    Article  Google Scholar 

  8. Lang, B. H., Chow, S. M., Lo, C. Y., Law, S. C. & Lam, K. Y. Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers. Ann. Surg. 246, 114–121 (2007).

    Article  Google Scholar 

  9. Jukkola, A., Bloigu, R., Ebeling, T., Salmela, P. & Blanco, G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr. Relat. Cancer 11, 571–579 (2004).

    Article  Google Scholar 

  10. Lundgren, C. I., Hall, P., Dickman, P. W. & Zedenius, J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case–control study. Cancer 106, 524–531 (2006).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chung-Yau Lo.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lang, B., Lo, CY. QTNM: a simplified TNM or just another staging system?. Nat Rev Endocrinol 5, 531–532 (2009). https://doi.org/10.1038/nrendo.2009.181

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.181

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing